Amazon cover image
Image from Amazon.com

Evidence-based management of lipid disorders / Maud N. Vissers, John J.P. Kastelein, Erik S. Stroes, [editors].

Contributor(s): Material type: TextTextPublisher: Harley : TFM, 2010Description: 1 online resource (326 pages) : illustrations (chiefly color)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781908986597
  • 190898659X
Subject(s): Genre/Form: Additional physical formats: Print version:: Evidence-based management of lipid disorders.DDC classification:
  • 616.399706 22
LOC classification:
  • RC632.L5 V57 2010eb
NLM classification:
  • 2010 I-616
  • WD 200.5.H8
  • WD 200.5.H8
Online resources:
Contents:
How much evidence is enough? / Daniel Steinberg -- A brief review of lipoprotein metabolism / Martin Adiels [and others] -- Epidemiological aspects of lipid and lipoprotein levels in relation to cardiovascular diseases / Jane Armitage, Louise Bowman, Sarah Lewington -- Are LDL cholesterol-lowering functional food ingredients successful in the long term? / Jogchum Plat, Ronald P. Mensink -- Evidence-based treatment of primary hypo- and hypercholesterolemic disorders / Tisha R. Joy, Robert A. Hegele -- Does raising HDL protect against atherosclerosis? / Menno Vergeer, G. Kees Hovingh -- How do we diagnose hypertriglyceridemia in clinical practice and what are the consequences for treatment? / Adie Viljoen, Anthony S. Wierzbicki -- The optimal treatment of patients with familial combined hyperlipidemia / Evertine J. Abbink, Jacqueline de Graaf, Anton F. Stalenhoef -- How to manage lipid and lipoprotein disorders in children / Serena Tonstad -- Contribution of the atherogenic dyslipidemic phenotype to the increased cardiovascular disease risk of the metabolic syndrome and diabetes mellitus / Benoit J. Arsenault, Jean-Pierre Després -- What are the consequences of renal insufficiency or the nephrotic syndrome for lipid levels? / Christiane Drechsler, Christoph Wanner, Ton Rabelink -- The link between chronic inflammatory diseases and cardiovascular risk / Michael T. Nurmohamed -- What is the evidence for a physiological and pathogenic role of lipoprotein (a)? / Sotirios Tsimikas -- Sitosterolemia; xenophobia for the body / Shailendra B. Patel, Gerald Salen -- How can we deal with inborn errors in cholesterol and bile acid biosynthesis? / Hester van Meer [and others] -- Differential diagnosis of patients with xanthomas and xanthelasmata / Peter J. Lansberg -- When should we fear statin interactions? / Rob E. Aarnoutse, David M. Burger -- What are the considerations in patients who are statin 'intolerant'? / Frans L. Opdam, Henk-Jan Guchelaar, Jouke T. Tamsma.
Item type:
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Home library Collection Call number Materials specified Status Date due Barcode
Electronic-Books Electronic-Books OPJGU Sonepat- Campus E-Books EBSCO Available

Includes bibliographical references and index.

Print version record.

How much evidence is enough? / Daniel Steinberg -- A brief review of lipoprotein metabolism / Martin Adiels [and others] -- Epidemiological aspects of lipid and lipoprotein levels in relation to cardiovascular diseases / Jane Armitage, Louise Bowman, Sarah Lewington -- Are LDL cholesterol-lowering functional food ingredients successful in the long term? / Jogchum Plat, Ronald P. Mensink -- Evidence-based treatment of primary hypo- and hypercholesterolemic disorders / Tisha R. Joy, Robert A. Hegele -- Does raising HDL protect against atherosclerosis? / Menno Vergeer, G. Kees Hovingh -- How do we diagnose hypertriglyceridemia in clinical practice and what are the consequences for treatment? / Adie Viljoen, Anthony S. Wierzbicki -- The optimal treatment of patients with familial combined hyperlipidemia / Evertine J. Abbink, Jacqueline de Graaf, Anton F. Stalenhoef -- How to manage lipid and lipoprotein disorders in children / Serena Tonstad -- Contribution of the atherogenic dyslipidemic phenotype to the increased cardiovascular disease risk of the metabolic syndrome and diabetes mellitus / Benoit J. Arsenault, Jean-Pierre Després -- What are the consequences of renal insufficiency or the nephrotic syndrome for lipid levels? / Christiane Drechsler, Christoph Wanner, Ton Rabelink -- The link between chronic inflammatory diseases and cardiovascular risk / Michael T. Nurmohamed -- What is the evidence for a physiological and pathogenic role of lipoprotein (a)? / Sotirios Tsimikas -- Sitosterolemia; xenophobia for the body / Shailendra B. Patel, Gerald Salen -- How can we deal with inborn errors in cholesterol and bile acid biosynthesis? / Hester van Meer [and others] -- Differential diagnosis of patients with xanthomas and xanthelasmata / Peter J. Lansberg -- When should we fear statin interactions? / Rob E. Aarnoutse, David M. Burger -- What are the considerations in patients who are statin 'intolerant'? / Frans L. Opdam, Henk-Jan Guchelaar, Jouke T. Tamsma.

English.

eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - Worldwide

There are no comments on this title.

to post a comment.

O.P. Jindal Global University, Sonepat-Narela Road, Sonepat, Haryana (India) - 131001

Send your feedback to glus@jgu.edu.in

Hosted, Implemented & Customized by: BestBookBuddies   |   Maintained by: Global Library